Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 545 of 1,261
  1. US 10076538

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  2. US 10076545

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  3. US 10077442

    Bioactive renal cells

    inRegen · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  4. US 10077424

    Methods of producing RPE cells and compositions of RPE cells

    Astellas Institute for Regenerative Medicine · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  5. US 10076533

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  6. US 10077444

    Compositions and methods for inhibiting expression of the LECT2 gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  7. US 10077311

    Human antibodies to GFR alpha3 and methods of reducing pain associated with GFR alpha3-related diseases

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  8. US 10077300

    Activatable binding polypeptides and methods of identification and use thereof

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  9. US 10076536

    Oligonucleotide analogues targeting human LMNA

    Sarepta Therapeutics, Inc. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  10. US 10072076

    Human antibodies to NAv1.7

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  11. US 10070632

    Rodents having a humanized TMPRSS gene

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  12. US 10071028

    Dental adhesive

    KURARAY NORITAKE DENTAL INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  13. US 10072243

    Derivation of embryonic stem cells and embryo-derived cells

    Astellas Institute for Regenerative Medicine · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  14. US 10072122

    Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereof

    BRIGHTGENE BIO-MEDICAL TECHNOLOGY (SUZHOU) CO., LTD. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  15. US 10072086

    Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  16. US 10073109

    Phages of biomarker capture and methods of use

    The Board of Regents of the University of Oklahoma · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  17. US 10072078

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  18. US 10072066

    Methods and compositions for treatment of a beta thalessemia

    Sangamo Therapeutics, Inc. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  19. US 10071979

    Process of producing cycloalkylcarboxamido-indole compounds

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  20. US 10072022

    Oridonin analogs, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  21. US 10071977

    Highly purifid pharmaceutical grade tasimelteon

    VANDA PHARMACEUTICALS INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  22. US 10071966

    Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

    Ludwig-Maximilians-Universitat Munchen · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  23. US 10071957

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  24. US 10072051

    Anti-inflammatory lipopeptide and preparing method and application thereof

    EAST CHINA NORMAL UNIVERSITY · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.